Synnot Anneliese, Ryan Rebecca, Prictor Megan, Fetherstonhaugh Deirdre, Parker Barbara
Centre for Health Communication and Participation, School of Public Health and Human Biosciences, La Trobe University, Bundoora, Vic, Australia, 3086.
Cochrane Database Syst Rev. 2014 May 9;2014(5):CD003717. doi: 10.1002/14651858.CD003717.pub3.
Informed consent is a critical component of clinical research. Different methods of presenting information to potential participants of clinical trials may improve the informed consent process. Audio-visual interventions (presented, for example, on the Internet or on DVD) are one such method. We updated a 2008 review of the effects of these interventions for informed consent for trial participation.
To assess the effects of audio-visual information interventions regarding informed consent compared with standard information or placebo audio-visual interventions regarding informed consent for potential clinical trial participants, in terms of their understanding, satisfaction, willingness to participate, and anxiety or other psychological distress.
We searched: the Cochrane Central Register of Controlled Trials (CENTRAL), The Cochrane Library, issue 6, 2012; MEDLINE (OvidSP) (1946 to 13 June 2012); EMBASE (OvidSP) (1947 to 12 June 2012); PsycINFO (OvidSP) (1806 to June week 1 2012); CINAHL (EbscoHOST) (1981 to 27 June 2012); Current Contents (OvidSP) (1993 Week 27 to 2012 Week 26); and ERIC (Proquest) (searched 27 June 2012). We also searched reference lists of included studies and relevant review articles, and contacted study authors and experts. There were no language restrictions.
We included randomised and quasi-randomised controlled trials comparing audio-visual information alone, or in conjunction with standard forms of information provision (such as written or verbal information), with standard forms of information provision or placebo audio-visual information, in the informed consent process for clinical trials. Trials involved individuals or their guardians asked to consider participating in a real or hypothetical clinical study. (In the earlier version of this review we only included studies evaluating informed consent interventions for real studies).
Two authors independently assessed studies for inclusion and extracted data. We synthesised the findings using meta-analysis, where possible, and narrative synthesis of results. We assessed the risk of bias of individual studies and considered the impact of the quality of the overall evidence on the strength of the results.
We included 16 studies involving data from 1884 participants. Nine studies included participants considering real clinical trials, and eight included participants considering hypothetical clinical trials, with one including both. All studies were conducted in high-income countries.There is still much uncertainty about the effect of audio-visual informed consent interventions on a range of patient outcomes. However, when considered across comparisons, we found low to very low quality evidence that such interventions may slightly improve knowledge or understanding of the parent trial, but may make little or no difference to rate of participation or willingness to participate. Audio-visual presentation of informed consent may improve participant satisfaction with the consent information provided. However its effect on satisfaction with other aspects of the process is not clear. There is insufficient evidence to draw conclusions about anxiety arising from audio-visual informed consent. We found conflicting, very low quality evidence about whether audio-visual interventions took more or less time to administer. No study measured researcher satisfaction with the informed consent process, nor ease of use.The evidence from real clinical trials was rated as low quality for most outcomes, and for hypothetical studies, very low. We note, however, that this was in large part due to poor study reporting, the hypothetical nature of some studies and low participant numbers, rather than inconsistent results between studies or confirmed poor trial quality. We do not believe that any studies were funded by organisations with a vested interest in the results.
AUTHORS' CONCLUSIONS: The value of audio-visual interventions as a tool for helping to enhance the informed consent process for people considering participating in clinical trials remains largely unclear, although trends are emerging with regard to improvements in knowledge and satisfaction. Many relevant outcomes have not been evaluated in randomised trials. Triallists should continue to explore innovative methods of providing information to potential trial participants during the informed consent process, mindful of the range of outcomes that the intervention should be designed to achieve, and balancing the resource implications of intervention development and delivery against the purported benefits of any intervention.More trials, adhering to CONSORT standards, and conducted in settings and populations underserved in this review, i.e. low- and middle-income countries and people with low literacy, would strengthen the results of this review and broaden its applicability. Assessing process measures, such as time taken to administer the intervention and researcher satisfaction, would inform the implementation of audio-visual consent materials.
知情同意是临床研究的关键组成部分。向临床试验潜在参与者呈现信息的不同方法可能会改善知情同意过程。视听干预(例如通过互联网或DVD呈现)就是这样一种方法。我们更新了2008年关于这些干预措施对试验参与知情同意影响的综述。
评估与标准信息或安慰剂视听干预相比,视听信息干预对于潜在临床试验参与者在知情同意方面的效果,包括他们的理解、满意度、参与意愿以及焦虑或其他心理困扰。
我们检索了以下数据库:Cochrane对照试验中心注册库(CENTRAL),《Cochrane图书馆》,2012年第6期;MEDLINE(OvidSP)(1946年至2012年6月13日);EMBASE(OvidSP)(1947年至2012年6月12日);PsycINFO(OvidSP)(1806年至2012年第1周);CINAHL(EbscoHOST)(1981年至2012年6月27日);《现刊目录》(OvidSP)(1993年第27周至2012年第26周);以及教育资源信息中心(ERIC)(Proquest)(检索于2012年6月27日)。我们还检索了纳入研究的参考文献列表和相关综述文章,并联系了研究作者和专家。没有语言限制。
我们纳入了随机和半随机对照试验,这些试验在临床试验的知情同意过程中,将单独的视听信息或与标准信息提供形式(如书面或口头信息)相结合的视听信息,与标准信息提供形式或安慰剂视听信息进行比较。试验涉及被要求考虑参与真实或假设临床研究的个人或其监护人。(在本综述的早期版本中,我们仅纳入了评估真实研究知情同意干预措施的研究)。
两位作者独立评估研究是否纳入并提取数据。我们尽可能使用荟萃分析综合研究结果,并对结果进行叙述性综合。我们评估了各个研究的偏倚风险,并考虑了总体证据质量对结果强度的影响。
我们纳入了16项研究,涉及1884名参与者的数据。9项研究纳入了考虑参与真实临床试验的参与者,8项纳入了考虑参与假设临床试验的参与者,1项同时纳入了两者。所有研究均在高收入国家进行。关于视听知情同意干预对一系列患者结局的影响仍存在很多不确定性。然而,综合各项比较来看,我们发现证据质量低至极低,表明此类干预可能会略微提高对主要试验的知识或理解,但对参与率或参与意愿可能几乎没有影响。视听形式的知情同意呈现可能会提高参与者对所提供同意信息的满意度。然而,其对该过程其他方面满意度的影响尚不清楚。没有足够的证据就视听知情同意引起的焦虑得出结论。我们发现关于视听干预实施所需时间或多或少存在相互矛盾且质量极低的证据。没有研究测量研究者对知情同意过程的满意度以及使用的便利性。对于大多数结局,来自真实临床试验的证据质量被评为低质量,对于假设性研究,则为极低质量。然而,我们注意到这在很大程度上是由于研究报告不佳、一些研究的假设性质以及参与者数量较少,而不是研究之间结果不一致或已证实的试验质量差。我们认为没有任何研究由对结果有既得利益的组织资助。
尽管在知识和满意度的改善方面出现了一些趋势,但视听干预作为一种有助于加强考虑参与临床试验的人的知情同意过程的工具,其价值在很大程度上仍不明确。许多相关结局尚未在随机试验中进行评估。试验者应继续探索在知情同意过程中向潜在试验参与者提供信息的创新方法,同时要考虑到干预应旨在实现的一系列结局,并在干预开发和实施的资源影响与任何干预的声称益处之间取得平衡。更多遵循CONSORT标准、在本综述中未充分涉及的环境和人群(即低收入和中等收入国家以及低识字率人群)中进行的试验,将加强本综述的结果并扩大其适用性。评估过程指标,如实施干预所需时间和研究者满意度,将为视听同意材料的实施提供信息。